Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -2.41%
March 31, 2026 15.49%
December 31, 2025 37.23%
September 30, 2025 30.78%
June 30, 2025 8.84%
March 31, 2025 2.02%
December 31, 2024 29.38%
September 30, 2024 26.74%
June 30, 2024 -29.71%
March 31, 2024 -15.23%
December 31, 2023 -50.35%
September 30, 2023 -37.97%
June 30, 2023 1.19%
Date Value
March 31, 2023 -6.73%
December 31, 2022 -27.28%
September 30, 2022 -1.12%
June 30, 2022 -8.38%
March 31, 2022 -9.86%
December 31, 2021 -15.93%
September 30, 2021 -26.48%
June 30, 2021 -8.59%
March 31, 2021 -4.55%
December 31, 2020 -31.21%
September 30, 2020 -14.40%
June 30, 2020 -78.98%
March 31, 2020 -35.24%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 52.64%
AngioDynamics, Inc. 56.00%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%
Baxter International, Inc. 33.55%

Gross Profit Margin (Quarterly) Related Metrics